Medpace Holdings, Inc. — Director's Dealing 2023

Dec 1, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2023-11-29

Reporting Person: Medpace Investors, LLC (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-29	Common Stock	S	3167	$272.87	Disposed	5639947	Direct
2023-11-29	Common Stock	S	18090	$272.62	Disposed	5621857	Direct
2023-11-30	Common Stock	S	7871	$272.18	Disposed	5613986	Direct
2023-12-01	Common Stock	S	24039	$273.26	Disposed	5589947	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.06 to $273.955. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.00 to $274.415. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F4: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.00 to $273.75. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F5: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.00 to $274.565. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.